Vaxcyte (PCVX) Assets (2019 - 2026)
Vaxcyte's Assets came in at $3.14 billion for Q2 2026, down 5.1% from $3.31 billion a year earlier and down 6.3% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte's Assets was $3 billion, down 14.5% from FY2024.
- Assets carries a five-year compound annual growth rate of 50.2% (FY2020 to FY2025).
- Going back by year, Assets was $3.51 billion in FY2024 (+149.4%), $1.41 billion in FY2023 (+39.9%), $1.01 billion in FY2022 (+210.2%) and $324.34 million in FY2021 (-17.4%).
- The five-year range for quarterly Assets is $324.34 million (Q4 2021) to $3.56 billion (Q3 2024).
- Year-over-year, Assets has declined for four consecutive quarters, with growth averaging 47.0% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q2 2023 (growth of 265.1%), and the weakest in Q4 2021 (a decline of 17.4%).
- Business Quant data shows PCVX's Assets at $3.35 billion (Q1 2026), $3 billion (Q4 2025) and $3.17 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - | 3.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.14 Bn |
| Mar 31, 2026 | 3.35 Bn |
| Dec 31, 2025 | 3.00 Bn |
| Sep 30, 2025 | 3.17 Bn |
| Jun 30, 2025 | 3.31 Bn |
| Mar 31, 2025 | 3.38 Bn |
| Dec 31, 2024 | 3.51 Bn |
| Sep 30, 2024 | 3.56 Bn |
| Jun 30, 2024 | 2.09 Bn |
| Mar 31, 2024 | 2.09 Bn |
| Dec 31, 2023 | 1.41 Bn |
| Sep 30, 2023 | 1.50 Bn |
| Jun 30, 2023 | 1.50 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 412.07 Mn |
| Jun 30, 2022 | 411.62 Mn |
| Mar 31, 2022 | 402.72 Mn |
| Dec 31, 2021 | 324.34 Mn |
| Sep 30, 2021 | 354.07 Mn |
API Access
Vaxcyte Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();